Shchelkovo Biocombinat took part at 10th World Congress of Vaccine-2017 in Singapore

In the period from November 15 to November 17, 2017, the delegation of Shchelkovo Biocombinat took part in the 10th Annual World Congress of Vaccine-2017, which was held in the Republic of Singapore. More than 1000 professionals gathered to exchange experiences and get acquainted with the latest developments in the field of vaccine development.

For the first time such a scientific event was held in 2008, in the following years a small profile conference turned into a popular scientific congress, uniting thousands of specialists working in the field of biotechnology and vaccine production.

The World Congress site provides an opportunity to support the traditions of great scientists, transfer knowledge to specialists from all over the world, and also serves as an excellent platform for interaction and fruitful cooperation of biotechnology experts from around the world to share knowledge on modern technologies, research and development of new generation vaccines.

The business program of the Congress included topics on the latest research and technology in the development of new generation vaccines, as well as the main trends in the development of the world market for immunobiological preparations for medical and veterinary purposes.

The main participants of the event are representatives of control and supervisory bodies of Singapore, leading experts of international pharmaceutical companies and experts of scientific research institutes.

The delegation of Shchelkovo Biocombinat held meetings with the aim of establishing new business ties and promoting veterinary drugs abroad.

Participation in the Congress was an excellent opportunity to get acquainted with the advanced technologies of vaccine manufacturing, demonstration, exchange of experience and discussion of actual veterinary problems.